Navigation Links
Quantros Acquires MediQual(TM) From CareFusion Corporation
Date:11/5/2009

SAN FRANCISCO, Nov. 5 /PRNewswire/ -- Quantros, Inc., an industry leader in healthcare data management, decision support analytics and prospective point of care data surveillance solutions, today announced the acquisition of MediQual(TM) from CareFusion Corporation (NYSE: CFN), a publicly traded company spun off from Cardinal Health earlier this year. Terms of the sale were not disclosed.

This latest addition to the Quantros suite of solutions adds clinical data analytics infrastructure for processing and managing expansive datasets and generating analytic profiles for use in decision support and outcomes management. MediQual currently supports clients nationwide in clinical analytics management and reporting efforts. MediQual's clinically-based risk models have been published, validated and nationally recognized by clinicians as critical to providing for more accurate prediction of healthcare outcomes. With years of demonstrated use, the automated clinical models bring efficiency to the generation of accurate comparisons among providers. Quantros has worked closely with the MediQual organization for the past two years as a strategic partner providing the underlying technology powering its Performance Measurement System (PMS) Core Measures solution.

"MediQual has been a valued Quantros partner and its solutions provide significant support and clinical insight for its clients," said Sanjaya Kumar, MD, President and CEO at Quantros. "We are excited about bringing this team and its solutions into the Quantros fold. With increasing national and state level focus on Pay-for-Performance and outcomes management, the need for next generation severity adjusted methodologies such as the MediQual severity adjustment models and solutions to provide integrated decision support become a critical need. The resulting solution enhancements and expanded customer support from this acquisition will benefit both MediQual and Quantros customers."

"Quantros has been a reliable partner for the past two years and its corporate mission and direction are in alignment with the ongoing quality management and analysis needs and requirements of the MediQual clients," said Tom Leonard, president of Dispensing Technologies for CareFusion. "We believe that this business is a good fit for Quantros and the ongoing needs of the MediQual customer base."

Quantros Establishes New East Coast Office in Marlborough, Massachusetts

As part of this acquisition, Quantros will open an office in Marlborough, Massachusetts. Quantros will be expanding its staff throughout the next 12 months and plans to house development, support, professional services and sales and marketing personnel at this location. Quantros is committed to furthering growth in this location and providing added support to its large, east coast base of clients.

"Quantros already has an expansive client footprint on the east coast, beyond those healthcare providers using MediQual solutions," commented Randy Everett, VP of Operations at Quantros. "This new facility will add jobs to the greater Boston area and provide expanded opportunities to better serve the combined Quantros and MediQual client base."

As part of this acquisition Quantros will transition existing MediQual staff into the Quantros team. MediQual brings with it an experienced group of professionals with an intimate knowledge of its clients and clinical analytics solutions. Quantros will look to expand this staff and provide an even greater level of customer involvement as it evaluates enhancements to the Atlas solution.

About Quantros

Quantros is a leading software and services provider for the healthcare industry in the areas of safety and risk management, quality and performance improvement, accreditation and compliance, real-time surveillance and centralized decision support. Today more than 2,000 healthcare facilities use Quantros solutions to improve performance and provide a safe, high quality environment of care.

Quantros is a healthcare information management technology company based in sound clinical discipline. Key product decisions are driven by experts in healthcare quality and performance improvement, safety, compliance, risk management and nursing. Quantros team members include physicians, nurses and healthcare professionals.

Visit Quantros on the web at www.quantros.com.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and Pulmonetic Systems ventilation and respiratory products, ChloraPrep® for infection prevention and MedMined(TM) services for infection surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.

SOURCE Quantros


'/>"/>
SOURCE Quantros
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Quantros Expands RRM Solution With New Quality Measures
2. CMH Regional Health System Adopts Quantros for Event Management and Reporting
3. Quantros and HealthWatch Announce PSO Partnership
4. Quantros and CACTUS Software Establish Strategic Alliance to Provide Customers With Comprehensive Provider Performance Monitoring
5. Passavant Area Hospital Adopts Quantros for Event Management and Reporting
6. Quantros Establishes IT Consulting Services Business Unit
7. Quantros Produces Video Detailing Enormous Problem of Preventable Medical Errors Plaguing The U.S. Healthcare System
8. The Nation's First Federally Certified Patient Safety Organization Chooses Quantros Patient Safety Organization Manager
9. Quantros President Appears on National TV Promoting Patient Safety
10. Quantros Director of Patient Safety and Risk Management is Elected Co-Chair of Patient Safety Work Group (PSWG) at HL7
11. Quantros Director of Patient Safety and Risk Management is Elected Co-Chair of Patient Safety Special Interest Group (PSSIG) at HL7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... 21, 2017 , ... The Margarian Law Firm has filed a class ... ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand of ... Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it is made ...
(Date:7/21/2017)... ... July 21, 2017 , ... “Kids aren't born knowing how to ... shoes,” says Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To ... Kickstarter on Monday, July 21st. , The kit uses colorful, engaging and educational ...
(Date:7/21/2017)... CANADA (PRWEB) , ... July 21, 2017 , ... ... torn anterior cruciate ligament (ACL) offer patients improved quality of life five years ... for Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. The study followed ...
(Date:7/20/2017)... Boston, MA (PRWEB) , ... July 20, 2017 ... ... aggressive form of blood and bone marrow cancer that progresses rapidly without treatment. ... often recommended to reduce the chance of reoccurrence and relapse. With such ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... in which their iMedSecure™ comes included with each system installation. RMT’s iMedHD2™ ... to remote participants for real-time collaboration and immediate decision-making requirements. While never ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... 2017  New York City-based market research firm Kalorama Information ... aware of.  From new products to new costs, to the ... recently completed study, Potential Pipeline Disruptors . ... 1.  Age-Driven Growth - True Impact Moment Arriving ... the impact the growing population and, to a more extreme ...
(Date:7/11/2017)... ROCKVILLE, Md. , July 11, 2017  The ... had estimated revenues of approximately $394.1 million in 2016.  ... a trend of solid growth, in particular as a ... oncology clinical practice, and the recent introduction of a ... the need for less-invasive testing of tumor biomarkers to ...
(Date:7/10/2017)... GAITHERSBURG, Md. , July 10, 2017 ... in non-animal test methods, is the recipient of a ... by the PETA International Science Consortium. The device, which ... be used to expose human lung cells to airborne ... lung. IIVS will use the VITROCELL® system for testing ...
Breaking Medicine Technology: